KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Net Income - Minority: 2017-2020

Historic Net Income - Minority for BeOne Medicines (ONC) over the last 2 years, with Sep 2020 value amounting to -$19.6 million.

  • BeOne Medicines' Net Income - Minority fell 24.37% to -$19.6 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$19.6 million, marking a year-over-year decrease of 24.37%. This contributed to the annual value of -$16.1 million for FY2019, which is 11.80% down from last year.
  • As of Q3 2020, BeOne Medicines' Net Income - Minority stood at -$19.6 million, which was down 92.26% from -$10.2 million recorded in Q2 2020.
  • BeOne Medicines' 5-year Net Income - Minority high stood at -$10.2 million for Q2 2020, and its period low was -$19.6 million during Q3 2020.
  • Its 3-year average for Net Income - Minority is -$15.0 million, with a median of -$14.8 million in 2020.
  • The largest annual percentage gain for BeOne Medicines' Net Income - Minority in the last 5 years was 41.37% (2020), contrasted with its biggest fall of 24.37% (2020).
  • Over the past 4 years, BeOne Medicines' Net Income - Minority (Quarterly) stood at -$14.4 million in 2017, then fell by 0.16% to -$14.4 million in 2018, then declined by 11.80% to -$16.1 million in 2019, then decreased by 24.37% to -$19.6 million in 2020.
  • Its last three reported values are -$19.6 million in Q3 2020, -$10.2 million for Q2 2020, and -$14.8 million during Q1 2020.